NCT05994807View on ClinicalTrials.gov

A Drug-Drug Interaction Study to Assess the Pharmacokinetics of DC-806 When Orally Administered Alone, When Coadministered With Itraconazole, and When Coadministered With Carbamazepine in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

August 8, 2023

Primary Completion Date

September 20, 2023

Study Completion Date

September 20, 2023

Conditions
Healthy Volunteers
Interventions
DRUG

DC-806

Oral tablets

DRUG

Itraconazole

Oral capsules

DRUG

Carbamazepine

Oral tablets

Trial Locations (1)

84124

ICON Phase I Clinic, Salt Lake City

All Listed Sponsors
lead

DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company

INDUSTRY

NCT05994807 - A Drug-Drug Interaction Study to Assess the Pharmacokinetics of DC-806 When Orally Administered Alone, When Coadministered With Itraconazole, and When Coadministered With Carbamazepine in Healthy Adult Participants | Biotech Hunter | Biotech Hunter